Straits Times Index
3,090.31 +17.32 (+0.56%) Nikkei
33,431.51 -55.38 (-0.17%) Hang Seng
16,830.30 -212.58 (-1.25%) FTSE 100
7,529.35 +75.60 (+1.01%) Bitcoin USD
39,436.74 +727.34 (+1.88%) CMC Crypto 200
802.76 +11.20 (+1.41%)
JNJ Jan 2024 85.000 call
| Previous close | 64.31 |
| Open | 64.20 |
| Bid | 73.50 |
| Ask | 74.30 |
| Strike | 85.00 |
| Expiry date | 2024-01-19 |
| Day's range | 64.20 - 64.35 |
| Contract range | N/A |
| Volume | |
| Open interest | 1 |
Insider MonkeyJP Morgan’s Top 15 Stock Picks for 2023 and Now
In this piece, we will take a look at JP Morgan’s top 15 stock picks for 2023 and most recent stock picks. If you want to skip our introduction to the world’s biggest bank in terms of assets, its latest performance, and other details, then check out JP Morgan’s Top 5 Stock Picks for 2023. […]
- Reuters
UPDATE 2-Pfizer is sued by Texas over COVID vaccine claims
Pfizer has been sued by Texas Attorney General Ken Paxton, who on Thursday accused the drugmaker of misrepresenting the efficacy of its widely-used COVID-19 vaccine. In a complaint filed in a Lubbock County state court, Paxton said it was misleading for Pfizer to claim its vaccine was 95% effective because it offered a "relative risk reduction" for people to who took it. Paxton said the claim was based on only two months of clinical trial data, and vaccine recipients' "absolute risk reduction" showed that the vaccine was just 0.85% effective.
Business WireJohnson & Johnson Names Eugene A. Woods, Chief Executive Officer of Advocate Health, to its Board of Directors
NEW BRUNSWICK, N.J., November 30, 2023--Johnson & Johnson (NYSE: JNJ) announced today that Eugene A. Woods, MBA, MHA, Chief Executive Officer of Advocate Health, has been appointed to its Board of Directors.
